25 May 2012

Abcam diversifies as interims advance

13/09/2011 Robert Tyerman

Online antibody distributor Abcam (ABC) is buying protein specialist Ascent Scientific after lifting annual pre-tax profits 25 per cent to £32.1 million. The Cambridge-based company, which increased turnover 17.1 per cent to £83.3 million in the year to June, is paying £10 million in cash and shares for Ascent, which generated annual turnover of £1.4 million supplying biochemicals enabling researchers to modulate the function of proteins.

Jonathan Milner, chief executive officer of AIM-quoted Abcam, says he is 'over the moon' about the Ascent deal, which will add Ascent's reagent range to the protein research tools which Abcam already supplies to the scientific community. He says this is part of the company's strategy of expanding into 'adjacent' areas, at a time when government cutbacks and fears of cutbacks have been making universities and other scientific customers in the USA and UK hesitant about their commitments.

According to Milner, Abcam, which upped earnings 23 per cent to 12.98p a share and proposes to hoist the full-year dividend 31 per cent to 5.25p a share, would like to spend some of its £55.6 million year-end cash pile on expanding further into immuno assays, measuring the interaction of molecular proteins, which he describes as 'the fastest growing part of our catalogue'. He argues the company, which paid £3.7 million in cash and shares for US protein research and detection tool maker MitoSciences in May, now faces a 'fragmented market' in the light of the feared cuts, with some areas still suffering and others, such as China and Germany, 'fine', while the USA 'has been recovering.'

Analysts at broker Peel Hunt expect Abcam, which has recruited Immunodiagnostic Systems chairman Tony Martin as a non-executive director, will increase pre-tax profits another 13.7 per cent to £36.5 million in the current year, with earnings ahead nearly 28 per cent to 14.6p a share and £42.6 million pre-tax with earnings of 16.8p a share on the cards for 2012-13. Growth Company Investor highlighted the shares at 330p last year and suggested partial profit taking at 413.75p two months ago.

Now 348p, down 2.75p this morning, they yield 1.5 per cent and value the company at £633.3 million, where they offer medium to long-term potential.

Tags: AIM market, Antibodies, Ascent Scientific, Immuno assays, Jonathan Milner, Tony Martin

Sector: Pharmaceuticals & Biotechnology

Companies: Abcam

Achieve impressive returns

Gain instant access to some of the best-performing and fastest growing companies in the small cap arena

Click here

Achieve impressive returns on the go

Gain instant access to some of the best-performing and fastest growing companies in the small cap arena. Sign up NOW!

Institutional Investors in AIM 2011 - New Report

This unique study analyses the shareholdings of companies listed on AIM, extracting trends including rankings of the value and number of their investments.
Please click here to order your copy of the report or call 0207 250 7056.

Coverage of AIM, techMARK and PLUS Markets

Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.

If you're interested in business tax updates visit our specialist tax guide website.

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Gulf starts at Sheikh Adi-2 25/05/2012

Iraq-focused oil explorer Gulf Keystone Petroleum (GKP) has begun drilling at the Sheikh Adi-2 well in the Sheikh Adi block.

Tags: Doing business in Iraq, Drilling on AIM, Oil on AIM

Sector: Oil & Gas Producers

Companies: Gulf Keystone Petroleum

Shell considers Cove 24/05/2012

Oil giant Shell is extending its offer period for Mozambique-focused Cove Energy (COV) after having its bid trumped by Thai government-owned PTT Exploration & Production.

Tags: Bid trumped, Doing business in Mozambique, Oil giants on AIM, Takeovers and bids

Sector: Oil & Gas Producers

Companies: Royal Dutch Shell 'A' , Cove Energy

Roxi reaches 1,360 metres 23/05/2012

Kazakhstan-focused Roxi Petroleum (RXP) has declared that its NK7 well in the Galaz aea has drilled to a depth of 1,360 metres.

Tags: AIM ventures, Doing business in Kazakhstan, Oil on AIM

Cluff Natural Resources joins AIM 22/05/2012

Steered by sector veteran Algy Cluff, North-Sea focused cash shell Cluff Natural Resources (CNR) has joined AIM.

Tags: Entrepreneurs on AIM, Gold mining, Oil and gas on AIM

Red Emperor exercises Shabeel 21/05/2012

Somalia-focused oil explorer Red Emperor Resources (RMP) has exercised its option to take part in the drilling of the Shabeel North well.

Tags: Business in the Puntland, Doing business in Somalia, Drilling for oil & gas, Oil on AIM

Sector: Oil & Gas Producers

Companies: Red Emperor Resources

Heritage happy in Iraq 18/05/2012

Oil concern Heritage Oil (HOIL) has reported its Miran West-3 well in Iraq could deliver 1,000 barrels per day of condensate.

Tags: Doing business in Iraq, Oil on the full list, Oil production, Target depth

Sector: Oil & Gas Producers

Companies: Heritage Oil

More News

Sectors